🟢 MetaVia is trading 6.32% up in pre-market with no clear catalyst identified

MetaVia is trading 6.32% up at $1.76, with no clear company-specific announcement or overnight catalyst identified for August 28, 2026.

• Its investor-relations feed lists the August 6, 2026 second-quarter results and corporate update as the latest press release.
• The move is occurring despite cautious U.S. futures, so broader market sentiment does not clearly explain the gain.
• The pre-market rally remains unconfirmed and may reflect low-liquidity trading or a delayed reaction to earlier biotechnology news.